Seroatlas · Human Serome Atlas

ADAMTSL5

ADAMTS-like protein 5

Also known as: ATL5_HUMAN

Cross-references: UniProt · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q6ZMM2
Gene
ADAMTSL5
Canonical length
481 aa
Protein class
Predicted intracellular proteins, Predicted secreted proteins

OverviewNCBI Gene

No narrative summary is available for ADAMTSL5 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

481 residues, UniProt reviewed canonical sequence.

>Q6ZMM2|ADAMTSL5
     1  MGKLRPGRVE WLASGHTERP HLFQNLLLFL WALLNCGLGV SAQGPGEWTP WVSWTRCSSS
    61  CGRGVSVRSR RCLRLPGEEP CWGDSHEYRL CQLPDCPPGA VPFRDLQCAL YNGRPVLGTQ
   121  KTYQWVPFHG APNQCDLNCL AEGHAFYHSF GRVLDGTACS PGAQGVCVAG RCLSAGCDGL
   181  LGSGALEDRC GRCGGANDSC LFVQRVFRDA GAFAGYWNVT LIPEGARHIR VEHRSRNHLA
   241  LMGGDGRYVL NGHWVVSPPG TYEAAGTHVV YTRDTGPQET LQAAGPTSHD LLLQVLLQEP
   301  NPGIEFEFWL PRERYSPFQA RVQALGWPLR QPQPRGVEPQ PPAAPAVTPA QTPTLAPDPC
   361  PPCPDTRGRA HRLLHYCGSD FVFQARVLGH HHQAQETRYE VRIQLVYKNR SPLRAREYVW
   421  APGHCPCPML APHRDYLMAV QRLVSPDGTQ DQLLLPHAGY ARPWSPAEDS RIRLTARRCP
   481  G

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ADAMTSL5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.37
Highest tissue expression
31 nTPM

Expression across tissuesHPA

Tissue

  • cervix: 31 nTPM
  • vagina: 23 nTPM
  • heart muscle: 21 nTPM
  • endometrium: 20 nTPM
  • esophagus: 15 nTPM
  • skeletal muscle: 14 nTPM

Single-cell type

  • cardiomyocytes: 41 nCPM
  • leydig cells: 23 nCPM
  • decidual stromal cells: 20 nCPM
  • peritubular myoid cells: 20 nCPM
  • myonuclei: 18 nCPM
  • esophageal apical cells: 14 nCPM

Immune cell

  • naive CD4 T-cell: 2 nTPM
  • memory CD4 T-cell: 1.6 nTPM
  • gdT-cell: 1.4 nTPM
  • naive CD8 T-cell: 1.3 nTPM
  • memory CD8 T-cell: 1.1 nTPM
  • MAIT T-cell: 0.9 nTPM

Brain region

  • choroid plexus: 21 nTPM
  • cerebellum: 7.8 nTPM
  • basal ganglia: 7.7 nTPM
  • hippocampal formation: 6.8 nTPM
  • amygdala: 6.6 nTPM
  • thalamus: 6.4 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ADAMTSL5.

Disease | ImmuneIEDB

Conditions an epitope on ADAMTSL5 was assayed in.

ReferencesPubMed · IEDB

Publications for ADAMTSL5 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.15
gnomAD pLI
0
gnomAD missense Z
-0.45
DepMap mean gene effect
-0.19
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ADAMTSL5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ADAMTSL5 as an antibody target. Whether an autoantibody or antibody against ADAMTSL5 could matter depends on whether native ADAMTSL5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ADAMTSL5 is annotated as secreted, so native ADAMTSL5 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label ADAMTSL5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ADAMTSL5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...